Med Aesthetics Sales Brief
Six signals · the decider map · three sharpest plays · the 2026 reality. Tuned to med aesthetics the way no generic prospecting tool will be.
Med Aesthetics . in 18 seconds
What changed for med aesthetics this year
The med spa base has passed 11,000 US locations and is still growing around 14 percent a year, but 2026 brings a state and federal enforcement wave against unlicensed injectors and compounded GLP-1s. Every enforcement action shakes loose accounts whose supply chain or medical directorship just got riskier. Medical-director filings and state license lookups make the compliant-vs-exposed map public.
Six signals fire when med aesthetics deals brew
Each one telegraphs a 90-day window worth chasing. Watched 24/7 from public sources.
The people who actually sign or block
The receptionist doesn't matter. These do. Your brief opens with the line that lands for the role on your calendar.
Six logos. One walk-in.
The incumbents you'll displace and the insurgents fighting for the same handle. Your brief tells you which one this account is shopping for today.
One opener. Three moves.
The actual brief line a med aesthetics rep used last week, plus the three sharpest plays baked into it.
“The state board just fined a spa two blocks from your top account for an unlicensed injector, and your account's owner reposted the coverage. Lead with compliance cover and loyalty economics, not price per unit.”
Same account. Two different walk-ins.
Generic AI gives you a horoscope. The Med Aesthetics pack gives you the next move.
“Med Aesthetics accounts operate in this vertical with industry-specific concerns. Recommendation: build rapport, ask discovery questions, identify pain points, and present your solution in a way that resonates.”
“The state board just fined a spa two blocks from your top account for an unlicensed injector, and your account's owner reposted the coverage. Lead with compliance cover and loyalty economics, not price per unit.”
What RepVantage brings to Med Aesthetics
The 2026 Med Aesthetics Sales Playbook
Six signals, the decider map, the three sharpest plays, and a per-vertical comparison of incumbent tools. Request it and Luke sends it to you personally.
The full Med Aesthetics read
Why Med Aesthetics prospecting changed in 2026
The med spa base has passed 11,000 US locations and is still growing around 14 percent a year, but 2026 brings a state and federal enforcement wave against unlicensed injectors and compounded GLP-1s. Every enforcement action shakes loose accounts whose supply chain or medical directorship just got riskier. Medical-director filings and state license lookups make the compliant-vs-exposed map public.
If you're a rep selling into med aesthetics accounts in 2026, the playbook from 2023 is dead. The decision-makers have moved. The signals worth tracking have moved. The competitors you should be displacing have moved. RepVantage's Med Aesthetics pack is the overlay that updates your read on every account, every time you pull a brief.
The reps who win this year aren't pulling harder. They're walking in with sharper reads - sourced from the exact signals that move med aesthetics buyers. That's what this pack ships.
Where the deals are right now
Six signals tend to fire in Med Aesthetics when a real procurement event is brewing. Each one telegraphs a 90-day window worth chasing.
1st signal - New med spa license or medical director filing. Source: State license lookup. 2nd signal - Enforcement action against injector. Source: State board actions · press. 3rd signal - Compounded GLP-1 supplier disruption. Source: FDA notices · trade press.
These aren't the only signals the pack surfaces, but they're the ones that move deals fastest in Med Aesthetics. Add lead injector changed practices, new location or expansion announced, loyalty program push detected and you've covered the bulk of the deal-creating events in any given week.
Who actually decides
The receptionist doesn't matter. The Medical Director does. In Med Aesthetics, the deciders worth tracking are: Medical Director, Spa Owner, Lead Injector, Practice Manager.
Each of these roles has a different read on what's worth buying, and our pack tunes the brief language to whoever's on your calendar. A Medical Director responds to different evidence than a Spa Owner, and our brief opens with the lead that lands for the person you're actually meeting.
Three plays that work right now
Here's the actual brief line a Med Aesthetics rep used last week on a real account: "The state board just fined a spa two blocks from your top account for an unlicensed injector, and your account's owner reposted the coverage. Lead with compliance cover and loyalty economics, not price per unit."
The three sharpest moves baked into that play: 1st. Compliance cover 2nd. Loyalty stack math 3rd. Injector-follow play.
That's the structure of every brief the Med Aesthetics pack generates - a one-line take, three numbered moves, and the receipts to back each one. The reps who walk in with those three moves don't waste the meeting trying to figure out where to land.
Why ZoomInfo, Apollo and Salesforce miss Med Aesthetics
Generic sales-prospecting tools serve everyone and excel at nobody. They give you a company record. RepVantage gives you a brief tuned to Med Aesthetics.
Where they list Allergan Aesthetics, Galderma, Merz as accounts, our Med Aesthetics pack tells you which of those are about to renew, which CFO just changed, and which signal in the last 11 days makes them shoppable right now. Tuning is the difference between walking in cold and walking in already knowing.
For a rep selling into med aesthetics, the question isn't "Can a generic tool find this account?" It's "Can my brief tell me about the New med spa license or medical director filing?" That's the line RepVantage is built across.
Common questions about the Med Aesthetics pack
Walk in already knowing Med Aesthetics.
The Med Aesthetics pack overlays every brief, tuned to the signals, players, and 2026 reality of your vertical. First three pulls are free.